Effect of VA-045 on central noradrenergic neuronal system in rats

General Pharmacology

Volumn 27, Issue 6, 1996, Pages 1013-1017

  Okuyama, Shigeru ^a   Yamada, Shigeyuki ^b   Ogawa, Shin Ichi ^a   Kawashima, Naoya ^a   Tomisawa, Kazuyuki ^a   Shima, Katsuji ^c   Kamata, Katsuo ^d  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b Nihon Bioresearch Inc   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d HOSHI UNIVERSITY   (Japan)

Author keywords

clonidine; closed head injury; DSP4; frontal cortex; microdialysis; rat locus coeruleus; VA 045

Indexed keywords

2 (NITROOXY)ETHYL APOVINCAMINATE; 2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; EBURNAMENINE 14 CARBOXYLIC ACID (2 NITROXYETHYL) ESTER; NEUROTOXIN; NORADRENALIN; PROTIRELIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DYSFUNCTION; BRAIN REGION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; ELECTROCHEMICAL DETECTION; FRONTAL CORTEX; HEAD INJURY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; RIGHTING REFLEX;

EID: 0030250706     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02136-1     Document Type: Article

References (19)

1. Arakawa S., Nakamura S., Kawashima N., Nishiike S. and Okuyama S. (1995) Antagonizing effects of VA-045 on reduced activity of rat locus coeruleus neurons following head injury or intravenous injection of clonidine. Life Sci. (in press).
2. 3H]idazoxan in rat brain. J. Pharmac. Exp. Ther. 241, 1079-1091.
3. Jonsson G., Hallman H. and Sundstrom E. (1982) Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat. Neuroscience. 7, 2895-2907.
4. Kawashima Y., Ikemoto T., Horiguchi A., Hayashi M., Matsumoto K., Kawarasaki K., Yamazaki R., Okuyama S. and Hatayama K. (1993) Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates. J. Med. Chem. 36, 815-819.
5. Marmarou A., Montasser A., Foda A.-E, Van Den Brink W., Campbell J., Kita, H. and Demetriadou K. (1994) A new model of diffuse brain injury in rats. Part 1: Pathophysiology and biomechanics. J. Neurosurg. 80, 291-300.
6. Miyamoto M., Nagai Y., Narumi S., Saji Y. and Nagawa Y. (1982) A TRH analog (DN-1417). TRH and its analog (DN-1417): antipentobarbital action and unvolvement of cholinergic mechanism. Pharmac. Biochem. Behav. 17, 797-806.
7. Miyata N., Yamaura H., Tanaka M., Muramatsu M., Tsuchida K., Okuyama S. and Otomo S. (1993) Effects of VA-045, a novel apovincaminic acid derivative, on isolated blood vessels: cerebroarterial selectivity. Life Sci. 52, 181-186.
8. Okuyama S., Shimamura H., Hashimoto S. and Aihara H. (1987) Relation between yawing behavior and central serotonergic neuronal system in rats. Naunyn-Schmiedeberg's Arch. Pharmac. 335, 667-672.
9. Okuyama S., Imagawa Y., Ogawa S., Araki H., Otomo S., Sakagawa T., Yamada S. and Shima K. (1993a) Effect of VA-045 on a closed head injury model in rats. Life Sci. 53, 273-278.
10. Okuyama S., Imagawa Y., Ogawa S., Saito Y., Araki H., Otomo S., Sakagawa T., Yamada S. and Shima K. (1993b) The effect of VA-045 on disturbance in consciousness in experimental animal models. Res. Comm. Chem. Path. Pharmac. 82, 91-100.
11. Okuyama S., Hashimoto-Kitsukawa S., Ogawa S., Imagawa Y., Kawashima K., Kawashima Y. Araki H. and Otomo S. (1994a) Effects of VA-045, a novel apovincaminic acid derivative, on age-related impairment evidence in electroencephalograph, caudate spindle, a passive avoidance task and cerebral blood flow in rats. Gen. Pharmac. 25, 1311-1320.
12. Okuyama S., Kawashima N., Araki H., Otomo S. and Shima K. (1994b) Effects of an apovincaminic derivative VA-045 on neuronal activity in rat brain stem reticular formation. Life Sci. 20, 1577-1584.
13. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney.
14. Ross B. S. (1976) Long-term effect of N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart. Br. J. Pharmac. 58, 521-527.
15. Suzuki M., Nishina M., Suga T., Matsushita K., Hoti E., Shima K. and Okuyama S. (1994) Cerebral energy metabolism in head-impacted rats and effects of VA-045 - investigation with in vivo 31P-NMR. Jpn. J. Pharmac. 64(suppl. 1), 197P.
16. Svensson T. H., Bunney B. S. and Aghajanian G. K. (1975) Inhibition of both noradrenergic and serotonergic neurons in the brain by the alpha-adrenergic agonist clonidine. Brain Res. 92, 291-308.
17. Uchiyama-Tsuyuki Y., Araki H., Okuyama S., Kawashima K. and Otomo S. (1993) VA-045 protects against hypoxia-induced neuronal injury in rat cortical culture. Jpn. J. Pharmac. 61(suppl. 1), 288P.
18. Yamada S., Yamaguchi K. and Okuyama S. (1994a) Cerebral protective effects of VA-045, a novel apovincaminic acid derivative in mice. Res. Commun. Mol. Path. Pharmac. 86, 83-91.
19. Yamada S., Yamaguchi K., Yoshida T., Kyuki K. and Okuyama S. (1994b) Effect of VA-045 on experimental brain ischemia. Jpn. J. Pharmac. 64(suppl. 1), 198P.